Delivery Order SPE2DB22D9316-SPE2DB25FYN95

Award Date 5/1/25
Potential Completion Date 5/22/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,878,290 units of CEREZYME 400 UNIT VIALS. The contract, valued at $7,881.60, has a period of performance through June 25, 2024. DMS Pharmaceutical Group Inc. is registered in the System for Award Management (SAM.gov) and has a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,881.60 contract is for the delivery of 4,566,545,300 units of the pharmaceutical product CEREZYME 400 UNIT VIALS. The contract has an ultimate completion date of December 6, 2024 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $14,418.03, is for the delivery of 4,567,903 units of CEREZYME 400 UNIT VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of April 22, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the supply of CEREZYME 400 unit vials, with an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $14,418.03 and covers the delivery of CEREZYME 400 UNIT VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a diverse array of branded and generic prescription...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,418.03, is for the delivery of CEREZYME 400 UNIT VIALS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc., valued at $499,999,999 and valid through November 2026. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $14,418.03 and covers the delivery of 4566955475 CEREZYME 400 UNIT VIALS. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $13,136.00 contract is for the delivery of CEREZYME 400 UNIT VIALS, a pharmaceutical product, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, valued up to $4,999,999 through 2025, for a broad range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of 4564944131 - CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA,...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN95
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $14,418.03, is for the delivery of 4,568,295,693 units of the pharmaceutical product CEREZYME 400 UNIT VIALS. The contract has a firm fixed price and is set to be completed by May 22, 2025.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 8/3/25, 1:24 AM